News Focus
News Focus
Followers 75
Posts 9957
Boards Moderated 1
Alias Born 07/17/2013

Re: BonelessCat post# 83748

Tuesday, 12/23/2014 9:24:10 AM

Tuesday, December 23, 2014 9:24:10 AM

Post# of 405181
Here's what we were expecting in your own words:

-Cohort 10 news for Kevetrin
-Phase 3 news for Brilacidin ABSSSI--FDA meeting outcomes including fast-track definitions
-Phase 2 start and protocol Brilacidin OM--FDA meeting outcomes including fast-track definitions
-Phase 2 or 2/3 news Prurisol--
-All 4 of the above.

Here's what we got:

-Positive Results of Brilacidin in Microbiological Intent-to-Treat Population in Phase 2b ABSSSI Trial
-Additional Pharmacokinetic Information to Be Submitted.
-IRB Approval to Start Oral Mucositis Trial
-Grant Awarded for HDP Mimics
-Biotech Showcase on Tap

Definitely not fluff. Definitely not what we were expecting.

You're not the least bit disappointed?

As always, in my opinion only. Do your own due diligence!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y